ArtVentive Medical Group, Inc. Announces New Catheter-Assisted Endovascular Tumor Treatment System

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTCBB: AVTD) announced today that the Company is expanding its product portfolio to include a unique and proprietary Catheter-Assisted Endovascular Tumor Treatment (CAETT™) system to deliver drugs and agents for minimally invasive, controlled and localized treatment of tumors.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC